Anticancer Therapies – News and Features

Researchers have developed a biobank with organoids derived from patients with head and neck cancer (HNC) and have used this biobank to validate known HNC biomarkers.

Researchers have identified how a specific gene mutation triggers an inflammatory cascade that may drive the development of treatment-resistant cancers.

A newly identified biomarker can indicate which patients with non-small cell lung cancer will respond well to chemoimmunotherapy

Researchers studying cell interactions in bowel cancer have identified innovative strategies to enhance how the body and drug treatments fight the disease.

Advanced kidney cancer progression was slowed by the addition of a targeted kinase inhibitor to a two-drug immunotherapy combination.

Research now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects.

According to research, elevated bone biomarkers were associated with an increased risk of death in men with hormone-sensitive prostate cancer.

Children with an inoperable type of brain cancer may benefit from an advanced immunotherapy treatment, according to new research.

Research suggests that AI-based population screening could be valuable in finding those at elevated risk for pancreatic cancer and could expedite diagnosis.

A novel approach to treating cancer uses bacteria that naturally reside within tumors to trigger a powerful anticancer immune response.